Coultreon Biopharma
Updated: May 03, 2026

CEO - Pierre Raboisson
Country: Belgium | Funding: $125M (+)
Founded: 2025
Website: https://www.coultreon.com/
CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.
Founded: 2025
Website: https://www.coultreon.com/
CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.





